Pliva D.D.
5Patents
0Active
5Granted
25Portfolio score
Filing activity: Sep 10, 2001 → Mar 17, 2003
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6855707B2 | Method for the treatment of lipid and glucose metabolism disorders | Human Necessities | 56 | Expired |
| US6852702B2 | 9a-N-[N′-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin A and of 5-O-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide A | Human Necessities | 4 | Expired |
| US7345048B2 | Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US6767917B1 | Amorphous torasemide modification | Human Necessities | 0 | Expired |
| US7202221B2 | Macrolides | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.